Go Pro
NYSEARCA:SBIO

ALPS Medical Breakthroughs ETF (SBIO) Price, Holdings, & News

ALPS Medical Breakthroughs ETF logo
$70.33 +1.69 (+2.46%)
As of 08/25/2026 04:10 PM Eastern

About ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO)

Advanced

Key Stats

Today's Range
$69.39
$70.59
50-Day Range
$54.25
$70.79
52-Week Range
$34.50
$70.85
Volume
86,746 shs
Average Volume
38,114 shs
Market Capitalization
$222.95 million
Assets Under Management
N/A
Dividend Yield
N/A
Net Expense Ratio
0.50%
Aggregate Rating
Moderate Buy

ETF Overview

The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.

ALPS Medical Breakthroughs ETF Expenses

TypeSBIOHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.50%0.55%0.57%0.51%0.53%
Other Expenses0.00%0.52%0.53%0.60%0.54%
Total Expense0.50%0.76%0.75%0.75%0.73%
Fee Waiver0.00%-0.85%-0.67%-0.77%-0.68%
Net Expense0.50%0.58%0.63%0.57%0.60%
Receive SBIO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ALPS Medical Breakthroughs ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SBIO ETF News Headlines

SBIO: Dividendenhistorie, Rendite und Ex-Dividenden-Tag
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security. The last time America reset its currency - under Nixon in the 1970s - it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump's initiative that could surge, plus his single top investment move.tc pixel
See More Headlines

SBIO ETF - Frequently Asked Questions

ALPS Medical Breakthroughs ETF's stock was trading at $51.22 at the beginning of 2026. Since then, SBIO shares have increased by 37.3% and is now trading at $70.33.

ALPS Medical Breakthroughs ETF's top institutional shareholders include Fulcrum Equity Management (0.14%) and Harbor Investment Advisory LLC (0.02%).

Shares of SBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ALPS Medical Breakthroughs ETF investors own include Waste Connections (WCN), American Water Works (AWK), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), AUO (AUOTY), DiamondRock Hospitality (DRH) and Triple Flag Precious Metals (TFPM).

Fund Details

Issuer
ALPS
Fund Name
ALPS Medical Breakthroughs ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:SBIO
Inception Date
12/30/2014
Fund Manager
Ryan Mischker, Andrew Hicks
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
S-Network Medical Breakthroughs Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
North America
Number of Holdings
109

Fund Statistics

Assets Under Management
$0.00
Average Daily Volume
$39.53 thousand
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
ALPS Fund Services, Inc.
Advisor
ALPS Advisors, Inc.
Custodian
State Street Bank and Trust Company
Distributor
ALPS Distributors, Inc.
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
GTS

Options

Optionable
Optionable
Options Volume
25
Put Options
4
Call Options
21
Short Interest
78,401 shs

Miscellaneous

Beta
0.74
Creation Unit
50,000
Creation Fee
$500.00
10 Stocks Powering The Next AI Boom  Cover

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

SBIO Sector Exposure

SBIO Industry Exposure


This page (NYSEARCA:SBIO) was last updated on 8/26/2026 by MarketBeat.com Staff.
From Our Partners